A scoring model for predicting prognosis of patients with severe fever with thrombocytopenia syndrome

PLoS Neglected Tropical Diseases

Volumn 11, Issue 9, 2017, Pages

  Jia, Bei ^a   Yan, Xiaomin ^a   Chen, Yuxin ^a   Wang, Guiyang ^a   Liu, Yong ^a   Xu, Biyun ^a   Song, Peixin ^a   Li, Yang ^a   Xiong, Yali ^a   Wu, Weihua ^a   Hao, Yingying ^a   Xia, Juan ^a   Zhang, Zhaoping ^a   Huang, Rui ^a   Wu, Chao ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COMPARATIVE STUDY; DISEASE CONTROL; DISEASE COURSE; FATIGUE; FEMALE; HEADACHE; HEMATOCRIT; HEMATURIA; HUMAN; HUMAN TISSUE; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MYALGIA; NEUTROPHIL COUNT; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SEVERE FEVER WITH THROMBOCYTOPENIA SYNDROME; AGED; BUNYAVIRIDAE INFECTIONS; CHINA; DECISION SUPPORT SYSTEM; HOSPITAL; ISOLATION AND PURIFICATION; MIDDLE AGED; PATHOLOGY; PHLEBOVIRUS; PROGNOSIS; THROMBOCYTOPENIA; VIROLOGY;

ADULT; AGED; BUNYAVIRIDAE INFECTIONS; CHINA; DECISION SUPPORT TECHNIQUES; FEMALE; HOSPITALS; HUMANS; MALE; MIDDLE AGED; PHLEBOVIRUS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTOPENIA;

EID: 85030724412     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0005909     Document Type: Article

References (26)

1. Liu L, Guan XH, Xing XS, Shen XF, Xu JQ, Yue JL, et al. [Epidemiologic analysis on severe fever with thrombocytopenia syndrome in Hubei province, 2010]. Zhonghua liu xing bing xue za zhi. 2012; 33 (2):168–72. 22575136.
2. Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011; 364(16):1523–32. doi: http://doi.org/10.1056/NEJMoa1010095 21410387.
3. Li Y, Zhou H, Mu D, Yin W, Yu H, Epidemiological analysis on severe fever with thrombocytopenia syndrome under the national surveillance data from 2011 to 2014, China]. Zhonghua liu xing bing xue za zhi. 2015; 36(6):598–602. 26564632.
4. Kurihara S, Satoh A, Yu F, Hayasaka D, Shimojima M, Tashiro M, et al. The world first two cases of severe fever with thrombocytopenia syndrome: An epidemiological study in Nagasaki, Japan. J Infect Chemother. 2016; 22(7):461–5. doi: http://doi.org/10.1016/j.jiac.2016.04.001 27142979.
5. Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, et al. Severe Fever with Thrombocytopenia Syndrome in South Korea, 2013–2015. PLoS Negl Trop Dis. 2016; 10(12):e0005264. doi: http://doi.org/10.1371/journal.pntd.0005264 28033338.
6. McMullan LK, Folk SM, Kelly AJ, MacNeil A, Goldsmith CS, Metcalfe MG, et al. A new phlebovirus associated with severe febrile illness in Missouri. N Engl J Med. 2012; 367(9):834–41. doi: http://doi.org/10.1056/NEJMoa1203378 22931317.
7. Liu Q, He B, Huang SY, Wei F, Zhu XQ, Severe fever with thrombocytopenia syndrome, an emerging tick-borne zoonosis. Lancet Infect Dis. 2014; 14(8):763–72. doi: http://doi.org/10.1016/s1473-3099(14)70718-2 24837566.
8. Xiong S, Zhang W, Li M, Xiong Y, Li M, Wang H, et al. A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients. Medicine (Baltimore). 2016; 95(52):e5708. doi: http://doi.org/10.1097/md.0000000000005708 28033271.
9. Guo CT, Lu QB, Ding SJ, Hu CY, Hu JG, Wo Y, et al. Epidemiological and clinical characteristics of severe fever with thrombocytopenia syndrome (SFTS) in China: an integrated data analysis. Epidemiol Infect. 2016; 144(6):1345–54. doi: http://doi.org/10.1017/s0950268815002678 26542444.
10. Liu S, Chai C, Wang C, Amer S, Lv H, He H, et al. Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol. 2014; 24(2):90–102. doi: http://doi.org/10.1002/rmv.1776 24310908.
11. Shin J, Kwon D, Youn SK, Park JH, Characteristics and Factors Associated with Death among Patients Hospitalized for Severe Fever with Thrombocytopenia Syndrome, South Korea, 2013. Emerg Infect Dis. 2015; 21(10):1704–10. doi: http://doi.org/10.3201/eid2110.141928 26402575.
12. Deng B, Zhou B, Zhang S, Zhu Y, Han L, Geng Y, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome Bunyavirus infection in Northeast China. PloS one. 2013; 8(11):e80802. doi: http://doi.org/10.1371/journal.pone.0080802 24236203.
13. Liu W, Lu QB, Cui N, Li H, Wang LY, Liu K, et al. Case-fatality ratio and effectiveness of ribavirin therapy among hospitalized patients in china who had severe fever with thrombocytopenia syndrome. Clin Infect Dis. 2013; 57(9):1292–9. Epub 2013/08/24. doi:http://doi.org/10.1093/cid/cit530 23965284.
14. Liu MM, Lei XY, Yu XJ, Meta-analysis of the clinical and laboratory parameters of SFTS patients in China. Virol J. 2016; 13(1):198. doi: http://doi.org/10.1186/s12985-016-0661-9 27899121.
15. Lee MJ, Kim KH, Yi J, Choi SJ, Choe PG, Park WB, et al. In vitro antiviral activity of ribavirin against severe fever with thrombocytopenia syndrome virus. Korean J Intern Med. 2016. doi: http://doi.org/10.3904/kjim.2016.109 27899013.
16. Wang L, Zou Z, Hou C, Liu X, Jiang F, Yu H, Score risk model for predicting severe fever with thrombocytopenia syndrome mortality. BMC Infect Dis. 2017; 17(1):42. doi: http://doi.org/10.1186/s12879-016-2111-0 28061758.
17. Cui N, Liu R, Lu QB, Wang LY, Qin SL, Yang ZD, et al. Severe fever with thrombocytopenia syndrome bunyavirus-related human encephalitis. J Infect Dis. 2015; 70(1):52–9. doi: http://doi.org/10.1016/j.jinf.2014.08.001 25135231.
18. Ding S, Niu G, Xu X, Li J, Zhang X, Yin H, et al. Age is a critical risk factor for severe fever with thrombocytopenia syndrome. PloS one. 2014; 9(11):e111736. doi: http://doi.org/10.1371/journal.pone.0111736 25369237.
19. Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012; 206(7):1095–102. doi: http://doi.org/10.1093/infdis/jis472 22850122.
20. Zhang YZ, He YW, Dai YA, Xiong Y, Zheng H, Zhou DJ, et al. Hemorrhagic fever caused by a novel Bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis. 2012; 54(4):527–33. doi: http://doi.org/10.1093/cid/cir804 22144540.
21. Wang M, Wang J, Wang T, Li J, Hui L, Ha X, Thrombocytopenia as a predictor of severe acute kidney injury in patients with Hantaan virus infections. PloS one. 2013; 8(1):e53236. doi: http://doi.org/10.1371/journal.pone.0053236 23301047.
22. Jin C, Liang M, Ning J, Gu W, Jiang H, Wu W, et al. Pathogenesis of emerging severe fever with thrombocytopenia syndrome virus in C57/BL6 mouse model. Proc Natl Acad Sci USA. 2012; 109(25):10053–8. doi: http://doi.org/10.1073/pnas.1120246109 22665769.
23. Yang ZD, Hu JG, Lu QB, Guo CT, Cui N, Peng W, et al. The prospective evaluation of viral loads in patients with severe fever with thrombocytopenia syndrome. J Clin Microbiol. 2016; 78:123–8. doi: http://doi.org/10.1016/j.jcv.2016.03.017 27062673.
24. Yoshikawa T, Fukushi S, Tani H, Fukuma A, Taniguchi S, Toda S, et al. Sensitive and specific PCR systems for detection of both Chinese and Japanese severe fever with thrombocytopenia syndrome virus strains and prediction of patient survival based on viral load. J Clin Microbiol. 2014; 52(9):3325–33. doi: http://doi.org/10.1128/jcm.00742-14 24989600.
25. Ding YP, Liang MF, Ye JB, Liu QH, Xiong CH, Long B, et al. Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clin Microbiol Infect. 2014; 20(11):O870–8. doi: http://doi.org/10.1111/1469-0691.12636 24684627.
26. Sun J, Gong Z, Ling F, Zhang R, Tong Z, Chang Y, et al. Factors associated with Severe Fever with Thrombocytopenia Syndrome infection and fatal outcome. Sci Rep. 2016; 6:33175. doi: http://doi.org/10.1038/srep33175 27605309.